FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Levocetirizine Dihydrochloride Tablets
Status: Discontinuation
»Therapeutic Categories: Pulmonary/Allergy

Apotex Corp. (New 01/21/2020)

Company Contact Information:
800-706-5575

Presentation Posting Date Related Information
5 mg tablets (NDCs 60505-3713-9 and 60505-3713-5) 01/21/2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English